{"url_path":"/sec/fth/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001193125-26-225333-index.html","accession_number":"0001193125-26-225333","cik":"0001829802","ticker":"FTH","issuer_name":"Faeth Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1829802/0001193125-26-225333-index.html","primary_entity_key":"0001829802","primary_entity_name":"Sensei Biotherapeutics, Inc."},"word_count":40,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\n(a) Recent Sales of Unregistered Equity Securities\n\nNone.\n\n(b) Use of Proceeds from Initial Public Offering of Common Stock\n\nNot applicable.\n\n(c) Issuer Purchases of Equity Securities\n\nNone.\n\n78"}